Pharma IQ Members

You are here

Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry

To better understand both the challenges faced by the global pharmaceutical industry in its pursuit of emerging-market opportunities and the strategies that leaders are employing to address them, Booz & Company surveyed executives from more than 25 of the top pharmaceutical and generics companies, other industry experts, and members of Booz & Company’s global pharmaceutical practice. The results paint a compelling picture of the hurdles and opportunities Pharma faces in pursuing perhaps its best opportunity for growth.

Matthias Buente, Stephan Danner, Susanne Weissbäcker, and Christoph Rammé
Have Your Say
Rate this feature and give us your feedback in the comments section below
Thank you, for your interest in Pharma Emerging Markets 2.0: How Emerging Markets Are Driving the Transformation of the Pharmaceutical Industry.
Rate this Whitepaper: 
Be the first!

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.

To continue viewing this content please fill out the form below and become a Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Enter your Pharmaceuticals & Biotechnology | Pharma & Biotech Resources username.
Enter the password that accompanies your username.
Forgot your password?

Or log in with...

Not a member?

Reasons for Joining
  • Address your challenges through knowledge sharing with peers from our global network of specialists.
  • Benchmark your business initiatives with the who's who in the field.
  • Hear from industry pioneers how to maximize ROI in today's challenging economy.
  • And best of all It's FREE!